StockStory identifies Hubbell as a leading S&P 500 stock while raising concerns about Charles River Laboratories and Verisk Analytics. The investment research firm published an analysis of three index constituents, categorizing Hubbell as a positive candidate and the other two as stocks to avoid or view with hesitation. The report highlights specific financial metrics to justify these distinctions, focusing on revenue growth, earnings performance, and valuation ratios.
Hubbell, which manufactures electronic products for construction, industrial, utility, and telecommunications markets, received the positive rating. The company reported a market capitalization of $25.05 billion. Over the last five years, Hubbell achieved 9.8% annual revenue growth, a figure that surpassed the sector average. This growth was accompanied by an 18.9% annual increase in earnings per share, a rate that outpaced its revenue gains due to share repurchases. Additionally, the company's free cash flow margin increased by 5.8 percentage points over the same five-year period. At a share price of $473.94, Hubbell trades at a forward P/E ratio of 21.8.
In contrast, StockStory advises caution regarding Charles River Laboratories. The company provides non-clinical drug development services and research models to pharmaceutical and biotechnology firms and was named after the Massachusetts river where it was founded in 1947. With a market capitalization of $14.41 billion, CRL faces scrutiny due to a lack of organic revenue growth over the past two years. The report notes that incremental sales over the last five years were less profitable, resulting in flat earnings per share. Furthermore, returns on capital have diminished from an already low starting point. Charles River Laboratories trades at $301.92 per share, representing a forward P/E of 24.2.
Verisk Analytics also drew hesitant ratings from the analysts. The company processes over 2.8 billion insurance transaction records annually and provides data and technology solutions to help insurers assess risk and detect fraud. Verisk has a market capitalization of $23.12 billion. Its annual revenue growth over the last five years was muted at 1.7%, lagging behind its business services peers. Earnings growth also underperformed the sector average over the last two years, with earnings per share growing by just 8% annually. The stock trades at $176.54 per share, or 21.5x forward P/E.
The analysis forms part of StockStory's broader effort to help investors navigate the market by distinguishing between companies with strong execution and those facing structural headwinds or weak financials.